Cited by 12SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPluripotent Stem Cells Research

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids

Open access

Published version of a preprint

Abstract

SARS-CoV-2 provokes devastating tissue damage by cytokine release syndrome and leads to multi-organ failure. Modeling the process of immune cell activation and subsequent tissue damage is a significant task. Organoids from human tissues advanced our understanding of SARS-CoV-2 infection mechanisms though, they are missing crucial components: immune cells and endothelial cells. This study aims to generate organoids with these components. We established vascular immune organoids from human pluripotent stem cells and examined the effect of SARS-CoV-2 infection. We demonstrated that infections activated inflammatory macrophages. Notably, the upregulation of interferon signaling supports macrophages’ role in cytokine release syndrome. We propose vascular immune organoids are a useful platform to model and discover factors that ameliorate SARS-CoV-2-mediated cytokine release syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-59405-9

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vascular-associated inflammatory readouts are relevant to inflammatory skin pathophysiology.

    “An important feature of the VSA system is its ability to assess vascular-associated inflammatory readouts, which are relevant to inflammatory skin pathophysiology [40][41][42] .”

    From Vascularized human skin assembloids model compartmental skin organization and immune responsiveness in vitro (2026) · cites this paper as [40]

    The Results report inflammatory gene signatures and IL6 in vascular immune organoids after SARS-CoV-2 infection, supporting the use of vascular-associated inflammatory readouts. The paper does not establish their relevance to inflammatory skin pathophysiology; its Discussion concerns COVID-19-related cytokine release and vascular damage, not skin disease. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. Siddiqi, H. K., Libby, P. & Ridker, P. M. COVID-19—A vascular disease. Trends Cardiovasc. Med. 31, 1–5 (2021). · DOI
  2. Pons, S., Fodil, S., Azoulay, E. & Zafrani, L. The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit. Care Lond. Engl. 24, 353 (2020). · DOI
  3. Sun, S.-H. et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 28, 124-133.e4 (2020). · DOI · Paper page
  4. Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758–763 (2022). · DOI
  5. Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107–113 (2021). · DOI
  6. Lamers, M. M. et al. SARS-CoV-2 productively infects human gut enterocytes. Science 369, 50–54 (2020). · DOI · Paper page
  7. Chen, K. G., Park, K. & Spence, J. R. Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids. Nat. Cell Biol. 23, 822–833 (2021). · DOI
  8. Kawakami, E. et al. Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19. Cell Stem Cell 30, 1315-1330.e10 (2023). · DOI
  9. Müller, J. A. et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 3, 149–165 (2021). · DOI
  10. Jansen, J. et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell 29, 217-231.e8 (2022). · DOI · Paper page
  11. Shimabukuro-Vornhagen, A. et al. Cytokine release syndrome. J. Immunother. Cancer 6, 56 (2018). · DOI
  12. Sprague, A. H. & Khalil, R. A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 78, 539–552 (2009). · DOI
  13. Arhontoulis, D. C. et al. Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries. J. Tissue Eng. Regen. Med. 16, 799–811 (2022). · DOI
  14. Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671–687 (2018). · DOI · Paper page
  15. Cao, H. et al. PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells. Life Sci. Alliance 7, e202302461 (2024). · DOI
  16. Ma, Z. et al. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Rep. 17, 538–555 (2022). · DOI
  17. Fontes-Dantas, F. L. et al. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. 42, 112189 (2023). · DOI
  18. Bhattacharya, M. et al. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 85, 104587 (2020).
  19. Choudhury, A. & Mukherjee, S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J. Med. Virol. 92, 2105–2113 (2020). · DOI
  20. Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221–224 (2020). · DOI · Paper page
  21. Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281-292.e6 (2020). · DOI · Paper page
  22. Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e8 (2020). · DOI · Paper page
  23. Wang, K. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target. Ther. 5, 283 (2020). · DOI
  24. Muhl, L. et al. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research. Stem Cell Rep. 17, 1089–1104 (2022). · DOI
  25. Hirunpattarasilp, C. et al. SARS-CoV-2 triggers pericyte-mediated cerebral capillary constriction. Brain J. Neurol. 146, 727–738 (2023). · DOI
  26. Kalejaiye, T. D. et al. SARS-CoV-2 employ BSG/CD147 and ACE2 receptors to directly infect human induced pluripotent stem cell-derived kidney podocytes. Front. Cell Dev. Biol. 10, 855340 (2022). · DOI
  27. Daly, J. L. et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370, 861–865 (2020). · DOI · Paper page
  28. Wimmer, R. A. et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature 565, 505–510 (2019). · DOI · Paper page
  29. Wörsdörfer, P. et al. Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Sci. Rep. 9, 15663 (2019). · DOI
  30. Gao, X. et al. Establishment of porcine and human expanded potential stem cells. Nat. Cell Biol. 21, 687–699 (2019). · DOI
  31. Chao, Y. et al. Organoid-based single-cell spatiotemporal gene expression landscape of human embryonic development and hematopoiesis. Signal Transduct. Target. Ther. 8, 230 (2023). · DOI
  32. Au-Yeung, R. K. H. et al. Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. Pediatr. Blood Cancer 68, e29285 (2021). · DOI

Cited by

Sorted by citations

Metadata

Authors
Chau, C. W., To, A., Au-Yeung, R. K. H., Tang, K., Xiang, Y., Ruan, D., Zhang, L., Wong, H., Zhang, S., Au, M. T., Chung, S., Song, E., Choi, D.-H., Liu, P., Yuan, S., Wen, C., & Sugimura, R.
Affiliations
  • University of Hong Kong (HK)
  • Hong Kong Polytechnic University (HK)
  • Korea University (KR)
Corresponding author
  • Wen, Chunyi
  • Sugimura, Ryohichi
Venue
Scientific Reports
Published
2024-04-16
Volume
14
Issue
1
Pages
8781-8781
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4394855728
Cited by
12
References
5
Citations by year
2026: 7 · 2025: 3 · 2024: 2
FWCI
4.15
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PolyU Institutional Research Archive (Hong Kong Polytechnic University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
SARS-CoV-2, inflammatory macrophages, cytokine release syndrome, interferon signaling, human pluripotent stem cells, endothelial cells, multiple organ failure, COVID-19 pathogenesis, disease modeling
MeSH terms
Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Macrophages, Organoids, Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review